XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 80 filers reported holding XENON PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $383,000 | +79.0% | 10,605 | +50.4% | 0.00% | +100.0% |
| Q2 2022 | $214,000 | -37.8% | 7,050 | -36.0% | 0.00% | 0.0% |
| Q4 2021 | $344,000 | +12.8% | 11,014 | -54.7% | 0.00% | -80.0% |
| Q2 2020 | $305,000 | +34.4% | 24,321 | +21.4% | 0.01% | -16.7% |
| Q1 2020 | $227,000 | -46.1% | 20,040 | -37.5% | 0.01% | +100.0% |
| Q4 2019 | $421,000 | -46.4% | 32,077 | -63.2% | 0.00% | -57.1% |
| Q3 2019 | $785,000 | -14.4% | 87,100 | -6.3% | 0.01% | -22.2% |
| Q2 2019 | $917,000 | +181.3% | 92,990 | +189.4% | 0.01% | +200.0% |
| Q1 2019 | $326,000 | – | 32,127 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 266,961 | $10,277,999 | 12.45% |
| COMMODORE CAPITAL LP | 1,845,000 | $71,032,500 | 7.98% |
| Altium Capital Management LP | 228,000 | $8,778,000 | 6.64% |
| TLS Advisors LLC | 33,756 | $1,300 | 5.58% |
| GREAT POINT PARTNERS LLC | 530,000 | $20,405,000 | 3.99% |
| DAFNA Capital Management LLC | 280,538 | $10,800,713 | 2.95% |
| Paradigm Biocapital Advisors LP | 989,327 | $38,089,090 | 2.94% |
| Nan Fung Group Holdings Ltd | 114,380 | $4,403,630 | 2.81% |
| Avoro Capital Advisors LLC | 4,900,000 | $188,650,000 | 2.56% |
| Ghost Tree Capital, LLC | 185,000 | $7,122,500 | 2.35% |